Terrexine DC 250 mg Intramammary Suspension for Dry Cows
Terrexine DC 250 mg Intramammary Suspension for Dry Cows
Authorised
This information is not available for this product.
Product identification
Medicine name:
Terrexine DC 250 mg Intramammary Suspension for Dry Cows
Arentor DC 250 mg suspensie voor intramammair gebruik bij droogstaande koeien
Active substance:
This information is not available for this product.
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle
-
Meat and offal21day
-
Milk96hour96 hours after calving if the dry period is longer than 54 days. 58 days following the treatment if the dry period is less than or equal to 54 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- A 3g coloured low density polyethylene intramammary syringe with a coloured low density polyethylene dual capPack sizes:Buckets of 120 intramammary syringes and 120 individually wrapped cleaning towels containing isopropyl alcohol.
- A 3g coloured low density polyethylene intramammary syringe with a coloured low density polyethylene dual capPack sizes:Cartons of 20 intramammary syringes and 20 individually wrapped cleaning towels containing isopropyl alcohol.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Univet Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Univet Limited
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 124023
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0522/001
Concerned member states:
-
Netherlands
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/01/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
How useful was this page?: